216 related articles for article (PubMed ID: 24920283)
1. Oxytocin, its antagonist Atosiban, and preterm labor: a role for placental nitric oxide.
Nanetti L; Raffaelli F; Giulietti A; Sforza G; Raffaele Giannubilo S; Ciavattini A; Tranquilli AL; Mazzanti L; Vignini A
J Matern Fetal Neonatal Med; 2015 Mar; 28(5):611-6. PubMed ID: 24920283
[TBL] [Abstract][Full Text] [Related]
2. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
European Atosiban Study Group
Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
[TBL] [Abstract][Full Text] [Related]
3. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group.
Valenzuela GJ; Sanchez-Ramos L; Romero R; Silver HM; Koltun WD; Millar L; Hobbins J; Rayburn W; Shangold G; Wang J; Smith J; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1184-90. PubMed ID: 10819856
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
[TBL] [Abstract][Full Text] [Related]
5. Atosiban.
Shubert PJ
Clin Obstet Gynecol; 1995 Dec; 38(4):722-4. PubMed ID: 8616970
[TBL] [Abstract][Full Text] [Related]
6. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
French/Australian Atosiban Investigators Group
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
[TBL] [Abstract][Full Text] [Related]
8. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
[TBL] [Abstract][Full Text] [Related]
9. Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban.
Bossmar T
J Perinat Med; 1998; 26(6):458-65. PubMed ID: 10224602
[TBL] [Abstract][Full Text] [Related]
10. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.
Goodwin TM; Paul R; Silver H; Spellacy W; Parsons M; Chez R; Hayashi R; Valenzuela G; Creasy GW; Merriman R
Am J Obstet Gynecol; 1994 Feb; 170(2):474-8. PubMed ID: 8116700
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin antagonists: clinical and scientific considerations.
Thornton S; Vatish M; Slater D
Exp Physiol; 2001 Mar; 86(2):297-302. PubMed ID: 11429647
[TBL] [Abstract][Full Text] [Related]
12. The effects of oxytocin and atosiban on the modulation of heart rate in pregnant women.
Weissman A; Tobia RS; Burke YZ; Maxymovski O; Drugan A
J Matern Fetal Neonatal Med; 2017 Feb; 30(3):329-333. PubMed ID: 27030149
[TBL] [Abstract][Full Text] [Related]
13. Barusiban, a new highly potent and long-acting oxytocin antagonist: pharmacokinetic and pharmacodynamic comparison with atosiban in a cynomolgus monkey model of preterm labor.
Reinheimer TM; Bee WH; Resendez JC; Meyer JK; Haluska GJ; Chellman GJ
J Clin Endocrinol Metab; 2005 Apr; 90(4):2275-81. PubMed ID: 15671092
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour.
Nisell H; Wolff K
BJOG; 2003 Jan; 110(1):89. PubMed ID: 12504956
[No Abstract] [Full Text] [Related]
15. The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.
Lyndrup J; Lamont RF
Expert Opin Investig Drugs; 2007 Jun; 16(6):843-53. PubMed ID: 17501696
[TBL] [Abstract][Full Text] [Related]
16. Development and clinical experience with the new evidence-based tocolytic atosiban.
Husslein P
Acta Obstet Gynecol Scand; 2002 Jul; 81(7):633-41. PubMed ID: 12190838
[TBL] [Abstract][Full Text] [Related]
17. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers.
Kim A; Shim JY
BJOG; 2006 Dec; 113 Suppl 3():113-5. PubMed ID: 17206978
[TBL] [Abstract][Full Text] [Related]
18. Atosiban and nifedipin for the treatment of preterm labor.
Kashanian M; Akbarian AR; Soltanzadeh M
Int J Gynaecol Obstet; 2005 Oct; 91(1):10-4. PubMed ID: 16043178
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin antagonists for tocolysis in preterm labour -- a systematic review.
Coomarasamy A; Knox EM; Gee H; Khan KS
Med Sci Monit; 2002 Nov; 8(11):RA268-73. PubMed ID: 12444392
[TBL] [Abstract][Full Text] [Related]
20. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group.
Goodwin TM; Valenzuela GJ; Silver H; Creasy G
Obstet Gynecol; 1996 Sep; 88(3):331-6. PubMed ID: 8752234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
